Abstract
Efficient delivery of cytidine analogues such as Azacitidine (AZA) into solid tumors constitutes a primary challenge in epigenetic therapies. We developed a di-block nano-vector based on poly(lactic-co-glycolic acid) (PLGA) and poly(ethylene glycol) (PEG) for stabilization of the conjugated AZA under physiological conditions. With equimolar drug content, our nano-conjugate could elicit a better anti-proliferative effect over free drug in breast cancer both in vitro and in vivo, through reactivation of p21 and BRCA1 to restrict cell proliferation. In addition, we applied single-molecule fluorescence tools to characterize the intracellular behavior of the AZA-PLGE-PEG nano-micelles at a finer spatiotemporal resolution. Our results suggest that the nano-micelles could effectively enrich in cancer cells and may not be limited by nucleoside transporters. Afterwards, the internalized nano-micelles exhibit pH-dependent release and resistance to active efflux. Altogether, our work describes a delivery strategy for DNA demethylating agents with nanoscale tunability, providing a cost-effective option for pharmaceutics.
Original language | English (US) |
---|---|
Pages (from-to) | 586-597 |
Number of pages | 12 |
Journal | Biomedicine and Pharmacotherapy |
Volume | 90 |
DOIs | |
State | Published - Jun 1 2017 |
Externally published | Yes |
Keywords
- Azacitidine
- DNA methylation
- Drug delivery
- Nanomedicine
- Single-molecule fluorescence
ASJC Scopus subject areas
- Pharmacology